Victoria Bedell, MD
Obstetrics & Gynecology · Miami, FLNPI 1306285952
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (59.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Eli Lilly accounts for 72.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $2,455 and has fallen 81.5% since, to $454 in 2025.
Across 70 payments — averaging $56.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$3K
- AbbVie$379
- Biotissue Holdings Inc.$194
- Sage Therapeutics, LLC$137
- Astellas Pharma US Inc$129
- Mylan Pharmaceuticals Inc.$79
- plus $185 from 8 others
Across 9 payments — averaging $179,224 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1.6M
What the payments were for
- Travel & lodging$2,36259%
- Food & beverage$1,49738%
- Education$1193%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 36 | $2,876 |
| AbbVie(2 entities) | 14 | $379 |
| Biotissue Holdings Inc. | 2 | $194 |
| Sage Therapeutics, LLC | 2 | $137 |
| Astellas Pharma US Inc | 3 | $129 |
| Mylan Pharmaceuticals Inc. | 4 | $79 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Myovant Sciences Inc. | 1 | $29 |
| Mayne Pharma Commercial LLC | 1 | $28 |
| AMAG Pharmaceuticals, Inc. | 1 | $25 |
| Bayer | 1 | $24 |
| Exeltis, USA Inc. | 1 | $21 |
| Lupin Inc. | 1 | $15 |
| Meditrina | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZULRESSO$120
- Prokera$115
- AmnioGraft$115
- AmnioGuard$115
- Orilissa$107
How this compares
$3,978 in reported general payments places this provider in the 85th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 33 | $2,717 |
| Estradiol (Once Weekly)Estradiol | 15 | $717 |
| ProgesteroneProgesterone, Micronized | 18 | $662 |
| Estradiol (Twice Weekly)Estradiol | 11 | $537 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Miami
- Youssef MouhayarMiami$162K
- Rebeca MartinezMiami$108K
- Jason JamesMiami$97K
- Peter KhamvongsaMiami$67K
- Abdulrahman SinnoMiami$67K
- Ingrid ParedesMiami$65K
- Karen Salazar ValdesMiami$29K
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.